GDTC Stock Analysis: Buy, Sell, or Hold?
GDTC - CytoMed Therapeutics Limited Ordinary Shares
$0.77
0.05 (6.44%)
▲
5d:
-20.92%
30d:
-23.02%
90d:
-34.21%
WAIT
LOW Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 04, 2026
0d
Get Alerted When GDTC Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: GDTC is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: GDTC is down 20.9% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: GDTC is currently trading at $0.77, which is considered oversold relative to its 30-day fair value range of $0.90 to $1.05.
Technical Outlook: Technically, GDTC is in a downtrend. Immediate support is located at $0.68, while resistance sits at $1.00. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+591.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GDTC is in a downtrend. Immediate support is located at $0.68, while resistance sits at $1.00. The stock is showing strong short-term momentum, up 6.4% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $5.00 (+591.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.90 -
$1.05
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
87.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+6.4%)
- BULLISH: Trading 591.4% below Wall St target ($5.00)
- WARNING: Recommendation downgraded due to -20.9% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$0.90 -
$1.05
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.68
Resistance Level
$1.00
Current Trend
Downtrend
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$5.00
(+591.4%)
Revenue Growth (YoY)
46.9%
Share & Embed Analysis
Last updated: May 08, 2026 2:45 PM ET
Data refreshes hourly during market hours. Next update: 3:45 PM
Data refreshes hourly during market hours. Next update: 3:45 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GDTC showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$548 | 60 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 54 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$875 | 52 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$79 | 57 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$119 | 57 HOLD |
